National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Drugs for Respiratory Syncytial Virus (RSV) Market Research Report 2021

Global Drugs for Respiratory Syncytial Virus (RSV) Market Research Report 2021

Goods_sn:tey

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Drugs for Respiratory Syncytial Virus (RSV) Market Research Report 2021

Hard Copy: 2900 USD
PDF Copy (single user): 2900 USD
Enterprise wide License: 3770 USD
Pages: 105
Tables and Figures: 118
Published Date: Aug 2016
Publisher: QYR Pharmaceuticals Research Center
Contact: Mr. Zhang Dong 86-10-82945717; 86-13811796901, sales@qyresearch.com

Summary

Notes:
Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)
Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies Drugs for Respiratory Syncytial Virus (RSV) in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
    Ablynx
    ADMA Biologics
    Agilvax
    AlphaVax
    AmVac
    Aridis Pharmaceuticals
    Artificial Cell Technologies
    Astellas Pharma
    AstraZeneca
    Bavarian Nordic
    Biota Pharmaceuticals
    Celltrion
    Codagenix
    Crucell
    CureVac
    Emergent
    Roche
    GenVec
    Gilead Sciences
    GlaxoSmithKline
    Humabs BioMed
    Novavax
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in these regions, from 2011 to 2021 (forecast), like
    North America
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Ribavirin
    Bronchodilator
    Type III
Split by application, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into
    Infants (Under 6 Month Old)
    Babies & Children
    Adults

Table of Contents

Global Drugs for Respiratory Syncytial Virus (RSV) Market Research Report 2021
1 Drugs for Respiratory Syncytial Virus (RSV) Overview
    1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
    1.2 Drugs for Respiratory Syncytial Virus (RSV) Segment by Types
        1.2.1 Global Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
        1.2.2 Ribavirin
        1.2.3 Bronchodilator
        1.2.4 Type III
    1.3 Drugs for Respiratory Syncytial Virus (RSV) Segment by Applications
        1.3.1 Infants (Under 6 Month Old)
        1.3.2 Babies & Children
        1.3.3 Adults
    1.4 Drugs for Respiratory Syncytial Virus (RSV) Market by Regions
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 China Status and Prospect (2011-2021)
        1.4.3 Europe Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 India Status and Prospect (2011-2021)
        1.4.6 Southeast Asia Status and Prospect (2011-2021)
    1.5 Global Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)
        1.5.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Revenue (2011-2021)
        1.5.2 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
        1.5.3 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)

2 Global Drugs for Respiratory Syncytial Virus (RSV) Market Competition by Manufacturers
    2.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Share by Manufacturers (2015 and 2016)
    2.2 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Manufacturers Drugs for Respiratory Syncytial Virus (RSV) Manufacturing Base Distribution and Product Type
    2.4 Competitive Situation and Trends
        2.4.1 Expansions
        2.4.2 New Product Launches
        2.4.3 Acquisitions
        2.4.4 Other Developments

3 Global Drugs for Respiratory Syncytial Virus (RSV) Analysis by Region
    3.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Market Share by Region (2011-2021)
        3.1.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Region (2011-2021)
        3.1.2 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Market Share by Region (2011-2021)
    3.2 North America
        3.2.1 North America Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.2.2 North America Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
    3.3 Europe
        3.3.1 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.3.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
    3.4 China
        3.4.1 China Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.4.2 China Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
    3.5 Japan
        3.5.1 Japan Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.5.2 Japan Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
    3.6 India
        3.6.1 India Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.6.2 India Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
    3.7 Southeast Asia
        3.7.1 Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
        3.7.2 Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)

4 Global Drugs for Respiratory Syncytial Virus (RSV) Analysis by Type
    4.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
        4.1.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
        4.1.2 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue, Market Share and Growth Rate by Type (2011-2021)
    4.2 Ribavirin Sales, Revenue, Price and Growth (2011-2021)
    4.3 Bronchodilator Sales, Revenue, Price and Growth (2011-2021)
    4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 Global Drugs for Respiratory Syncytial Virus (RSV) Market Analysis by Application
    5.1 Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)
    5.2 Major Regions Drugs for Respiratory Syncytial Virus (RSV) Sales by Application in 2015 and 2016
        5.2.1 North America Drugs for Respiratory Syncytial Virus (RSV) Sales by Application
        5.2.2 Europe Drugs for Respiratory Syncytial Virus (RSV) Sales by Application
        5.2.3 China Drugs for Respiratory Syncytial Virus (RSV) Sales by Application
        5.2.4 Japan Drugs for Respiratory Syncytial Virus (RSV) Sales by Application
        5.2.5 India Drugs for Respiratory Syncytial Virus (RSV) Sales by Application
        5.2.6 Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales by Application

6 Global Drugs for Respiratory Syncytial Virus (RSV) Manufacturers Analysis
    6.1 Ablynx
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.1.2.1 Ribavirin
            6.1.2.2 Bronchodilator
            6.1.2.3 Type III
        6.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
    6.2 ADMA Biologics
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.2.2.1 Ribavirin
            6.2.2.2 Bronchodilator
            6.2.2.3 Type III
        6.2.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
    6.3 Agilvax
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.3.2.1 Ribavirin
            6.3.2.2 Bronchodilator
            6.3.2.3 Type III
        6.3.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
    6.4 AlphaVax
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.4.2.1 Ribavirin
            6.4.2.2 Bronchodilator
        6.4.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
    6.5 AmVac
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.5.2.1 Ribavirin
            6.5.2.2 Bronchodilator
        6.5.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
    6.6 Aridis Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.6.2.1 Ribavirin
            6.6.2.2 Bronchodilator
        6.6.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
    6.7 Artificial Cell Technologies
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.7.2.1 Ribavirin
            6.7.2.2 Bronchodilator
        6.7.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
    6.8 Astellas Pharma
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.8.2.1 Ribavirin
            6.8.2.2 Bronchodilator
        6.8.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
    6.9 AstraZeneca
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.9.2.1 Ribavirin
            6.9.2.2 Bronchodilator
        6.9.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
    6.10 Bavarian Nordic
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Drugs for Respiratory Syncytial Virus (RSV) Product Overview
            6.10.2.1 Ribavirin
            6.10.2.2 Bronchodilator
        6.10.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
    6.11 Biota Pharmaceuticals
    6.12 Celltrion
    6.13 Codagenix
    6.14 Crucell
    6.15 CureVac
    6.16 Emergent
    6.17 Roche
    6.18 GenVec
    6.19 Gilead Sciences
    6.20 GlaxoSmithKline
    6.21 Humabs BioMed
    6.22 Novavax

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Figure Global Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
Table Drugs for Respiratory Syncytial Virus (RSV) Product Type of by Manufacturers
Table Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application in 2015 and 2016
Figure North America Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure China Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Japan Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure India Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Revenue (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table Manufacturers Drugs for Respiratory Syncytial Virus (RSV) Manufacturing Base Distribution and Product Type
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market by Region (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market by Region (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Region (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Market by Region (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Market Share by Region (2011-2021)
Table North America Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure North America Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure Europe Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
Table China Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure China Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure Japan Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
Table India Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure India Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Growth Rate  (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue by Type (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)
Figure Ribavirin Sales, Revenue and Growth (2011-2021)
Figure Ribavirin Price Trend (2011-2021)
Figure Bronchodilator Sales, Revenue and Growth (2011-2021)
Figure Bronchodilator Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2011-2021)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application in 2015
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application in 2021
Table North America Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table Europe Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table China Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table Japan Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table India Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table Southeast Asia Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2015 and 2016)
Table Global Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Figure Global Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Table Ablynx Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
Table ADMA Biologics Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
Table Agilvax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
Table AlphaVax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
Table AmVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table Artificial Cell Technologies Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table AstraZeneca Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Bavarian Nordic Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
Table Biota Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)
Table Celltrion Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)
Table Codagenix Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)
Table Crucell Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)
Table CureVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)
Table Emergent Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)
Table Roche Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)
Table GenVec Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Humabs BioMed Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)
Table Novavax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)

Request sample If you need any reports sample, just let us know.